Discovery of Novel c-Met Inhibitors Bearing a 3-Carboxyl Piperidin-2-one Scaffold

By Zhang Wei   Ai Jing   Shi Dakuo   Peng Xia   Ji Yinchun   Liu Jian   Geng Meiyu   Li Yingxia  

Molecules, Vol. 19, Iss. 2, 2014-02 ,pp. : 2655-2673

MDPI

Access to resources Recommend Favorite

Discovery of 2-(4-Substituted-piperidin/piperazine-1-yl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-quinazoline-2,4-diamines as PAK4 Inhibitors with Potent A549 Cell Proliferation, Migration, and Invasion Inhibition Activity

By Wu Tianxiao   Pang Yu   Guo Jing   Yin Wenbo   Zhu Mingyue   Hao Chenzhou   Wang Kai   Wang Jian   Zhao Dongmei   Cheng Maosheng  

Molecules, Vol. 23, Iss. 2, 2018-02 ,pp. : 417-417

MDPI

Access to resources Recommend Favorite

Role of cMET in the Development and Progression of Colorectal Cancer

By Pérez-Vargas Juan Carlos Samamé   Biondani Pamela   Maggi Claudia   Gariboldi Manuela   Gloghini Annunziata   Inno Alessandro   Volpi Chiara Costanza   Gualeni Ambra Vittoria   di Bartolomeo Maria   de Braud Filippo   Castano Alessandra   Bossi Ilaria   Pietrantonio Filippo  

International Journal of Molecular Sciences, Vol. 14, Iss. 9, 2013-09 ,pp. : 18056-18077

MDPI

Access to resources Recommend Favorite

Assessing Scaffold Diversity of Kinase Inhibitors Using Alternative Scaffold Concepts and Estimating the Scaffold Hopping Potential for Different Kinases

By Dimova Dilyana   Bajorath Jürgen  

Molecules, Vol. 22, Iss. 5, 2017-05 ,pp. : 730-730

MDPI

Access to resources Recommend Favorite

Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors

By Sun Shaofeng   Zhang Jingwen   Wang Ningning   Kong Xiangkai   Fu Fenghua   Wang Hongbo   Yao Jianwen  

Molecules, Vol. 23, Iss. 1, 2017-12 ,pp. : 24-24

MDPI

Access to resources Recommend Favorite